Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Pemetrexed disodium and erlotinib may stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth. Giving pemetrexed disodium together with
erlotinib may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the side effects and best dose of two different
schedules of pemetrexed disodium and erlotinib and to see how well they work in treating
patients with advanced non-small cell lung cancer or other solid tumors.